Home β€Ί Stock analysis β€Ί AAPG

Ascentage Pharma Group International (AAPG) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

AAPG jumps 4.6% to $15.37 on 2.3x normal volume. Closed at $15.37, +4.63% vs the prior close of $14.69. Day range $14.80–$15.53, opened at $14.80.

Last close$15.37+4.63%
Day range14.80–15.53
Open14.80
Volume15.09K
52-week range14.45–37.50
Avg volume (20d)7.70K

AAPG daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” AAPG jumps 4.6% to $15.37 on 2.3x normal volume
Oct 15, 2026 β€” AAPG dips 1.1% to $14.69, 3 down days in a row
Oct 14, 2026 β€” AAPG dips 1.4% to $14.85
Oct 13, 2026 β€” AAPG dips 1.6% to $15.06
Oct 12, 2026 β€” AAPG jumps 3.8% to $15.31
Oct 9, 2026 β€” AAPG rises 1.4% to $14.75
Oct 8, 2026 β€” AAPG dips 2.6% to $14.55, a 52-week low on 1.8x normal volume
Oct 7, 2026 β€” AAPG slides 7.1% to $14.94
Oct 6, 2026 β€” AAPG jumps 10.2% to $16.09 on 2.3x normal volume
Oct 5, 2026 β€” AAPG slides 4.9% to $14.60, a 52-week low, 3 down days in a row
Oct 2, 2026 β€” AAPG slides 3.4% to $15.36

AAPG latest news & SEC filings

Every SEC filing by or about AAPG in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 15, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-109623

Sep 29, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-104196

Sep 17, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-100763

Aug 20, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-091901

Aug 13, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-088773

Aug 5, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-085424

Aug 3, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-084247

Jul 27, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-081816

Jul 20, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-079420

Jul 20, 2026 Β· Form F-3ASR β€” F-3ASR filing

F-3ASR filing

Source: SEC EDGAR filing 0001213900-26-079362

Jul 13, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-077607

Jun 30, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-073699

Jun 29, 2026 Β· Form 3 β€” New insider holdings

Initial insider ownership statement (Form 3) β€” a new director, officer or 10% owner disclosed their holdings

Source: SEC EDGAR filing 0001213900-26-073067

Things to know before you trade AAPG

AAPG market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 202614.8015.5314.8015.3715.09K
Oct 15, 202614.6914.9314.4714.699.00K
Oct 14, 202615.0615.0614.8414.853.40K
Oct 13, 202615.0616.0714.8315.0610.30K
Oct 12, 202615.1915.4515.1915.314.60K
Oct 9, 202614.5014.8014.5014.751.20K
Oct 8, 202614.8914.8914.4514.5512.00K
Oct 7, 202615.1415.4014.8514.947.20K
Oct 6, 202615.2216.0915.2216.0914.50K
Oct 5, 202614.7614.7914.5814.603.60K
Oct 2, 202615.2515.6014.8915.369.00K
Oct 1, 202615.7916.0215.6515.904.30K
Sep 30, 202615.5916.5015.5916.3113.70K
Sep 29, 202615.3016.0415.3015.353.40K
Sep 28, 202615.0015.0114.5514.894.80K
Sep 25, 202614.8115.0314.8114.862.90K
Sep 24, 202615.0115.2314.8515.2315.40K
Sep 23, 202615.7115.7115.5815.581.50K
Sep 22, 202616.0216.1815.8715.87800
Sep 21, 202615.9116.1715.8215.8617.40K

About Ascentage Pharma Group International

Ascentage Pharma Group International (AAPG) is listed on the Nasdaq and classified by the SEC under β€œPharmaceutical Preparations”. Its business address is in SUZHOU , JIANGSU. State of incorporation: Cayman Islands. Fiscal year ends December 31. SEC CIK 2023311.

AAPG board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Marina BozilenkoDirectorMar 23, 2026
Marc E LippmanDirectorMar 23, 2026
Simon Dazhong LuDirectorMar 23, 2026
David SidranskyDirectorMar 23, 2026
Shaomeng WangDirectorMar 23, 2026
Ren WeiDirectorMar 23, 2026
Dajun YangChairman and CEOMay 22, 2026
Changqing YeDirectorMar 23, 2026
Debra YuDirectorMar 23, 2026

Executive officers

NameTitleLatest filing
Jin CaoChief Accounting OfficerApr 20, 2026
Thomas J KnappSVP/General CounselMar 23, 2026
Veet MisraChief Financial OfficerApr 21, 2026
Faical MiyaraChief Business OfficerJun 29, 2026
Dajun YangChairman and CEOMay 22, 2026
Yifan ZhaiChief Medical OfficerMay 22, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
No open-market insider buys or sales reported in the last 12 months.

AAPG financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
No annual XBRL figures available (foreign filers often report on Form 20-F).

Latest balance sheet: total assets $β€”, total liabilities $β€”, cash $β€”.

AAPG earnings / results-day log

DateFilingClose that day
No 8-K earnings releases in recent filings.

Related stocks Β· Pharmaceutical Preparations

Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on AAPG

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.